Unlocking Intracellular Protein Delivery by Harnessing Polymersomes Synthesized at Microliter Volumes using Photo‐PISA
Chalaisorn Thanapongpibul,Omar Rifaie‐Graham,Miina Ojansivu,Adrian Najer,Hyemin Kim,Saskia E. Bakker,Mohamed Chami,David J. Peeler,Chenchen Liu,Jonathan Yeow,Molly M. Stevens
DOI: https://doi.org/10.1002/adma.202408000
IF: 29.4
2024-10-19
Advanced Materials
Abstract:Efficient intracellular delivery of therapeutic proteins is challenging due to poor cell membrane permeation and endolysosomal entrapment. An oxygen tolerant Photo‐PISA process is reported for the microliter‐scale synthesis of polymersomes that deliver proteins into the cytosol and activate antigen‐presenting cells. This high throughput approach is a highly promising strategy for the screening of early‐stage therapeutic proteins and vaccine antigen candidates. Efficient delivery of therapeutic proteins and vaccine antigens to intracellular targets is challenging due to generally poor cell membrane permeation and endolysosomal entrapment causing degradation. Herein, these challenges are addressed by developing an oxygen‐tolerant photoinitiated polymerization‐induced self‐assembly (Photo‐PISA) process, allowing for the microliter‐scale (10 μL) synthesis of protein‐loaded polymersomes directly in 1536‐well plates. High‐resolution techniques capable of analysis at a single particle level are employed to analyze protein encapsulation and release mechanisms. Using confocal microscopy and super‐resolution stochastic optical reconstruction microscopy (STORM) imaging, their ability to deliver proteins into the cytosol following endosomal escape is subsequently visualized. Lastly, the adaptability of these polymersomes is exploited to encapsulate and deliver a prototype vaccine antigen, demonstrating its ability to activate antigen‐presenting cells and support antigen cross‐presentation for applications in subunit vaccines and cancer immunotherapy. This combination of ultralow volume synthesis and efficient intracellular delivery holds significant promise for unlocking the high throughput screening of a broad range of otherwise cost‐prohibitive or early‐stage therapeutic protein and vaccine antigen candidates that can be difficult to obtain in large quantities. The versatility of this platform for rapid screening of intracellular protein delivery can result in significant advancements across the fields of nanomedicine and biomedical engineering.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology